Johnson & Johnson vaccine to remain on pause
The Center for Disease Control and Prevention (CDC) said the Johnson & Johnson COVID-19 vaccine will remain on pause as an investigation continues on the recent reports of severe blood clots, NBC News reports.
Experts advisors said they do not yet have enough information to make any new recommendations on the Johnson & Johnson vaccine.
The CDC held a meeting Wednesday with the Advisory Committee on Immunization Practices (ACIP), an independent panel of health experts, outside of the CDC.
Officials agreed the Johnson & Johnson vaccine should remain on pause for now with a final decision to be made in the coming weeks.
The CDC, and the FDA, first recommended the pause Tuesday after six people developed rare but serious blood clots after getting the Johnson & Johnson vaccine shots.
The Food and Drug Administration (FDA) could also change Johnson & Johnson’s emergency use authorization which currently allows anyone 18 and older to receive the vaccine, NBC News reports.
Every US state has temporarily stopped administering the Johnson & Johnson vaccine.